Table 2 Events, crude incidence rates and hazard ratios of events in the two treatment groups
Statin use (N = 10,682) | None (N = 2043) | |
|---|---|---|
Composite outcomea | ||
No of events/person-years | 878/42,484 | 217/7032 |
Absolute ratesb (95% CI) | 20.7 (19.3–22.1) | 30.9 (27.0–35.3) |
HRc (95% CI) | 1 (reference) | 1.53 (1.32–1.77) |
aHRd (95% CI) | 1 (reference) | 1.36 (1.15–1.62) |
All-cause mortality | ||
No of events/person-years | 415/43,503 | 177/7098 |
Absolute rates (95% CI) | 9.5 (8.7–10.5) | 24.9 (21.5–28.9) |
HR (95% CI) | 1 (reference) | 2.61 (2.19–3.12) |
aHR (95% CI) | 1 (reference) | 1.89 (1.51–2.37) |
Acute myocardial infarction (AMI) | ||
No of events/person-years | 60/43,377 | 5/7094 |
Absolute rates (95% CI) | 1.4 (1.1–1.8) | 0.7 (0.3–1.7) |
HR (95% CI) | 1 (reference) | 0.50 (0.20–1.25) |
aHR (95% CI) | 1 (reference) | 0.88 (0.35–2.23) |
Non-fatal stroke | ||
No of events/person-years | 401/42,643 | 34/7051 |
Absolute rates (95% CI) | 9.4 (8.5–10.4) | 4.8 (3.4–6.7) |
HR (95% CI) | 1 (reference) | 0.51 (0.36–0.72) |
aHR (95% CI) | 1 (reference) | 0.55 (0.38–0.81) |